Astrana Health (ASTH) Tops Q4 EPS by 11c; offers guidance

Astrana Health (NASDAQ: ASTH) reported Q4 EPS of $0.26, $0.11 better than the analyst estimate of $0.15. Revenue for the quarter came in at $353 million versus the consensus estimate of $342 million.

GUIDANCE:

Astrana Health sees FY2024 EPS of $1.28-$1.52, versus the consensus of $1.59.

Astrana Health sees FY2024 revenue of $1.650-1.850 billion.

For earnings history and earnings-related data on (ASTH) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Academy Sports and Outdoor (ASO) Misses Q1 EPS by 1c ; Offers Guidance
• Limoneira (LMNR) Misses Q2 EPS by 8c, Beats on Revenue